Education
About Us
Working with TipRanks
Follow Us
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
MRVI Stock Chart & Stats
$3.25
$0.02(0.33%)
At close: 4:00 PM EST
$3.25
$0.02(0.33%)
Day’s Range― - ―
52-Week Range$1.67 - $6.34
Previous CloseN/A
Volume457.32K
Average Volume (3M)1.66M
Market Cap
$732.89M
Enterprise Value$726.02M
Total Cash (Recent Filing)$243.57M
Total Debt (Recent Filing)$35.85M
Price to Earnings (P/E)―
Beta1.70
Next Earnings
Feb 25, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding144,677,780
10 Day Avg. Volume1,703,881
30 Day Avg. Volume1,663,195
Financial Highlights & Ratios
PEG Ratio-0.31
Price to Book (P/B)2.31
Price to Sales (P/S)2.90
P/FCF Ratio-33.87
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue3.78
Enterprise Value/Gross Profit18.10
Enterprise Value/Ebitda-4.63
Forecast
1Y Price Target
$4.33Price Target Upside33.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$191.96M
Bulls Say, Bears Say
Bulls Say
Business OutlookThe underlying business seems to be tracking toward a year of growth based on management’s review and current visibility into order momentum.
Financial GuidanceManagement reiterated its positive adjusted EBITDA and free cash flow targets it set last quarter.
Management StrategyManagement believes it now has the right pieces in place to right-size the organization, stabilize operations, and accurately forecast the business with a high level of confidence.
Bears Say
Earnings MissMaravai reported third-quarter results that missed consensus on the top and bottom lines.
Financial PerformanceThird-quarter results were lighter than expected.
Guidance WithdrawalGuidance for 2025 was withdrawn as the new management team is conducting a comprehensive review of the business.
Maravai Lifesciences Holdings News
MRVI FAQ
What was Maravai Lifesciences Holdings’s price range in the past 12 months?
Maravai Lifesciences Holdings lowest stock price was $1.67 and its highest was $6.34 in the past 12 months.
What is Maravai Lifesciences Holdings’s market cap?
Maravai Lifesciences Holdings’s market cap is $732.89M.
When is Maravai Lifesciences Holdings’s upcoming earnings report date?
Maravai Lifesciences Holdings’s upcoming earnings report date is Feb 25, 2026 which is in 105 days.
How were Maravai Lifesciences Holdings’s earnings last quarter?
Maravai Lifesciences Holdings released its earnings results on Nov 06, 2025. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.082 by $0.002.
Is Maravai Lifesciences Holdings overvalued?
According to Wall Street analysts Maravai Lifesciences Holdings’s price is currently Undervalued.
Does Maravai Lifesciences Holdings pay dividends?
Maravai Lifesciences Holdings does not currently pay dividends.
What is Maravai Lifesciences Holdings’s EPS estimate?
Maravai Lifesciences Holdings’s EPS estimate is -0.07.
How many shares outstanding does Maravai Lifesciences Holdings have?
Maravai Lifesciences Holdings has 144,677,780 shares outstanding.
What happened to Maravai Lifesciences Holdings’s price movement after its last earnings report?
Maravai Lifesciences Holdings reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.082. Following the earnings report the stock price went down -0.692%.
Which hedge fund is a major shareholder of Maravai Lifesciences Holdings?
Currently, no hedge funds are holding shares in MRVI
Maravai Lifesciences Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.33 (33.23% Upside)
$4.33 (33.23% Upside)
Blogger Sentiment
Bullish
MRVI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 675.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 3.6%
Last 30 Days ▲ 2.6%
Last 30 Days ▲ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-38.91%
12-Months-Change
Fundamentals
Return on Equity
-41.06%
Trailing 12-Months
Asset Growth
-33.56%
Trailing 12-Months
Company Description
Maravai Lifesciences Holdings
Maravai Lifesciences Holdings (MRVI) is a leading provider of life sciences tools and services, focused on enabling the development of new therapies and the advancement of scientific research. The company operates primarily in three sectors: nucleic acid production, protein detection, and cell line development. Its core products include custom nucleic acids, detection reagents, and cell line development services, which are critical for applications in genomics, diagnostics, and biopharmaceutical manufacturing.
MRVI Company Deck
MRVI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant cost reductions and new product innovations, indicating potential for future growth. However, it was overshadowed by substantial revenue declines and negative EBITDA, primarily due to order timing and macroeconomic challenges.View all MRVI earnings summariesMRVI Revenue Breakdown
77.79% Nucleic Acid Production
22.21% Biologics Safety Testing
MRVI Stock 12 Month Forecast
Average Price Target
$4.33
▲(33.23% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---